BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27736839)

  • 1. Increase in Adverse Reactions Associated with Use of Synthetic Cannabinoids - Anchorage, Alaska, 2015-2016.
    Springer YP; Gerona R; Scheunemann E; Shafer SL; Lin T; Banister SD; Cooper MP; Castrodale LJ; Levy M; Butler JC; McLaughlin JB
    MMWR Morb Mortal Wkly Rep; 2016 Oct; 65(40):1108-1111. PubMed ID: 27736839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic cannabinoids: the dangers of spicing it up.
    Salani DA; Zdanowicz MM
    J Psychosoc Nurs Ment Health Serv; 2015 May; 53(5):36-43. PubMed ID: 25974923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation following synthetic cannabinoid abuse.
    Efe TH; Felekoglu MA; Çimen T; Doğan M
    Turk Kardiyol Dern Ars; 2017 Jun; 45(4):362-364. PubMed ID: 28595208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the experience of using synthetic cannabinoids by means of interpretative phenomenological analysis.
    Kassai S; Pintér JN; Rácz J; Böröndi B; Tóth-Karikó T; Kerekes K; Gyarmathy VA
    Harm Reduct J; 2017 Feb; 14(1):9. PubMed ID: 28187774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic cannabinoids and potential reproductive consequences.
    Sun X; Dey SK
    Life Sci; 2014 Feb; 97(1):72-7. PubMed ID: 23827241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Not for human consumption": a review of emerging designer drugs.
    Musselman ME; Hampton JP
    Pharmacotherapy; 2014 Jul; 34(7):745-57. PubMed ID: 24710806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulopathic hemorrhage with use of synthetic cannabinoids.
    Boyack I; Opsha O
    Am J Emerg Med; 2019 Feb; 37(2):374.e3-374.e4. PubMed ID: 30409461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute kidney injury associated with smoking synthetic cannabinoid.
    Buser GL; Gerona RR; Horowitz BZ; Vian KP; Troxell ML; Hendrickson RG; Houghton DC; Rozansky D; Su SW; Leman RF
    Clin Toxicol (Phila); 2014 Aug; 52(7):664-73. PubMed ID: 25089722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe illness associated with reported use of synthetic cannabinoids: a public health investigation (Mississippi, 2015).
    Kasper AM; Ridpath AD; Gerona RR; Cox R; Galli R; Kyle PB; Parker C; Arnold JK; Chatham-Stephens K; Morrison MA; Olayinka O; Preacely N; Kieszak SM; Martin C; Schier JG; Wolkin A; Byers P; Dobbs T
    Clin Toxicol (Phila); 2019 Jan; 57(1):10-18. PubMed ID: 29989463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic cannabinoid intoxication: a case series and review.
    Harris CR; Brown A
    J Emerg Med; 2013 Feb; 44(2):360-6. PubMed ID: 22989695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe Illness Associated with Reported Use of Synthetic Cannabinoids - Mississippi, April 2015.
    Kasper AM; Ridpath AD; Arnold JK; Chatham-Stephens K; Morrison M; Olayinka O; Parker C; Galli R; Cox R; Preacely N; Anderson J; Kyle PB; Gerona R; Martin C; Schier J; Wolkin A; Dobbs T
    MMWR Morb Mortal Wkly Rep; 2015 Oct; 64(39):1121-2. PubMed ID: 26447715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reports of adverse health effects related to synthetic cannabinoid use in New York State.
    Papadopoulos EA; Cummings KR; Marraffa JM; Aldous KM; Li L; Ahmad N
    Am J Addict; 2017 Dec; 26(8):772-775. PubMed ID: 29105968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ["Spice"--synthetic cannabinoids with dangerous effects].
    Personne M; Westerbergh J; Hammer-Pettersen L
    Lakartidningen; 2014 Nov; 111(47):2105-7. PubMed ID: 25386644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic Cannabinoid and Mitragynine Exposure of Law Enforcement Agents During the Raid of an Illegal Laboratory - Nevada, 2014.
    Tapp L; Ramsey JG; Wen A; Gerona R
    MMWR Morb Mortal Wkly Rep; 2017 Dec; 66(47):1291-1294. PubMed ID: 29190268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Top 10 Facts You Need to Know About Synthetic Cannabinoids: Not So Nice Spice.
    Kemp AM; Clark MS; Dobbs T; Galli R; Sherman J; Cox R
    Am J Med; 2016 Mar; 129(3):240-4.e1. PubMed ID: 26522795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designer Drugs 2.0.
    Huestis MA; Tyndale RF
    Clin Pharmacol Ther; 2017 Feb; 101(2):152-157. PubMed ID: 28084644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical increase in synthetic cannabinoid emergency-related presentations after a citywide ban: Lessons from Houston, Texas.
    Mathai D; Gordon M; Muchmore P; Matorin A; Shah A; Moukaddam N
    Bull Menninger Clin; 2016; 80(4):357-370. PubMed ID: 27936903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter retrospective survey of poisoning after consumption of products containing synthetic chemicals in Japan.
    Kamijo Y; Takai M; Fujita Y; Hirose Y; Iwasaki Y; Ishihara S; Yokoyama T; Yagi K; Sakamoto T
    Intern Med; 2014; 53(21):2439-45. PubMed ID: 25366001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Notes from the field: severe illness associated with reported use of synthetic marijuana - Colorado, August-September 2013.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Dec; 62(49):1016-7. PubMed ID: 24336136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An outbreak of acute delirium from exposure to the synthetic cannabinoid AB-CHMINACA.
    Tyndall JA; Gerona R; De Portu G; Trecki J; Elie MC; Lucas J; Slish J; Rand K; Bazydlo L; Holder M; Ryan MF; Myers P; Iovine N; Plourde M; Weeks E; Hanley JR; Endres G; St Germaine D; Dobrowolski PJ; Schwartz M
    Clin Toxicol (Phila); 2015; 53(10):950-6. PubMed ID: 26555732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.